This study aims to investigate whether tamoxifen, a representative of selective estrogen receptor modulators (SERMs), can induce changes in DNA methylation patterns in breast cancer cells with varying levels of GPER and ESR expression. The gene discussed is ESR1; the disease is breast carcinoma.